Enter assignee name

% Expired Patents = 27.3

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 268

Loading Chart...

7 inventors (with patents filed for the assignee):

Britta Hardy (6 out of 11 patents)

Leah Klapper (6 out of 6 patents)

Rinat Rotem-Yehudar (5 out of 5 patents)

4. Michael Schickler (3 out of 3 patents)

5. Steven Tarran Jones (3 out of 14 patents)

6. Annat Raiter (3 out of 6 patents)

7. Galina Rodionov (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 9580504 - Pidilizumab monoclonal antibody therapy following stem cell transplantation (2017-02-28),

2. 9416175 - Variants of humanized immunomodulatory monoclonal antibodies (2016-08-16),

3. 9309308 - Monoclonal antibodies for tumor treatment (2016-04-12),

4. 8747847 - Monoclonal antibodies for tumor treatment (2014-06-10),

5. 8686119 - Variants of humanized immunomodulatory monoclonal antibodies (2014-04-01),

6. 7981416 - Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency (2011-07-19),

7. 7745397 - Peptide useful in immunomodulation (2010-06-29),

8. 7524498 - Human immunomodulatory monoclonal antibodies for the treatment of cancer (2009-04-28),

9. 7332582 - Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency (2008-02-19),

10. 7329639 - Peptide useful in immunomodulation (2008-02-12),

11. 7122372 - Peptide useful in immunomodulation (2006-10-17),

Curetech Ltd. is a leading biotechnology company specializing in developing novel therapeutics for cancer and autoimmune diseases. With a focus on innovative research and cutting-edge technologies, Curetech is dedicated to improving the lives of patients worldwide. The company's pipeline includes promising drug candidates that target specific molecular pathways to combat disease. Visit our website to learn more about our groundbreaking work.

Profile summary based on public USPTO records.